Page 11 - Beckley Psytech News Today

The portrait taken with her pigeon Birdie just after the procedure In 1970, Amanda Feilding caused a furore after drilling a hole into her own skull (yes, really!). After decades of being dismissed as an oddball, her belief in the benefits of psychedelic drugs is suddenly being taken seriously   I am not really in love with ketamine,’ states Amanda Feilding, the Countess of Wemyss and March. It’s a rather startling revelation for a 78-year-old woman of impeccable manners who looks as thou...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. United Kingdom-based startup Beckley Psytech is gearing up for a Phase 1 clinical trial investigating a synthetic version of 5-MeO-DMT. The trial is looking at the benefits of this unique psychedelic as a treatment of neuropsychiatric diseases.  5-MeO-DMT is an unlikely psychedelic compound. It’s not a plant or fungus — it’s excreted through the skin of the Son...

California’s legislature could soon be discussing a new bill meant to decriminalize psychedelic substances. On Tuesday, State Senator Scott Wiener announced via Twitter his intention to introduce a new bill aimed at pulling back on penalties for the non-commercial use of these drugs, first... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

Woman has suffered a non-stop headache for eight years Rebecca McDonoughs headache first struck like an electric shock in 2012 Rebecca in 2013 (Image: PA REAL LIFE) There are always big stories on WalesOnline - dont miss any with our daily emailInvalid EmailSomething went wrong, please try again later. Sign me up now When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice. Thank you for subscrib...

Noetic Fund II LP: Noetic Launches Second Fund to Invest in Emergent Psychedelic Medicine Sector Having successfully launched one of the first funds operating in the nascent psychedelic medicine space, Toronto-based venture capital firm Noetic is now launching a second, larger Fund. TORONTO, ON / ACCESSWIRE / March 4, 2021 / The "Noetic Funds," founded by the team at Grey House Partners GP Inc., has announced the launch of Noetic Fund II LP ("Fund II"), a venture capital fund that is seeking to...

Alexander_Volkov/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The psychedelics industry has ramped up over the past year as institutional investors entered and several companies have gone public. Insider identified the top 14 startups that are working to turn psychedelics into approved medicines for conditions like depression, opioid use disorder, and anxiety. ...

Beckley Psytech This story is available exclusively to Insider subscribers. Become an Insider and start reading now. UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round, backed by investment firms Noetic Psychedelic Fund and Bail Capital. Beckley Psytechs upcoming clinical trials will be focused on researching the synthetic compound 5-MeO-DMT, a psychedelic agent found naturally in the Sonoran...

Reuters Welcome to Insider Cannabis, our weekly newsletter where were bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom. Happy Friday readers, Cannabis deal mania continued this week, led by the news that Tilray and Aphria are merging in a $4 billion deal. I spoke to Aphria CEO Irwin Simon and Tilray CEO Brendan Kennedy after the announcement. They said that the merger clearly positions the "new...

Deals of the Week, December 11 to 18 – Growth Business roundup 18 Dec 2020 Growth Business roundup of Deals of the Week December 11 to 18, listing seed funding, venture capital and crowdfunding deals of note Triple support for eXate with three investors raising £2.3m in seed round eXate, a London-based data software firm, has announced a £2.3m seed round led by Outward VC, with additional backing from ING Ventures and Triple Point Ventures. The funding will enable eXate to gro...

Neo Kuma Ventures is a new venture fund in London thats just for investing in psychedelics. Psychedelics are mind-altering substances, like the psilocybin found in magic mushrooms.  Early research suggests that psychedelics could be used to treat health conditions, like mental illnesses resistant to conventional treatments.  Psychedelics is an emerging industry worldwide, separate to cannabis. Canada, the US and Europe are frontrunners. Neo Kumas 35-year-old co-founder shared her strategy for...